BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1696 related articles for article (PubMed ID: 8808867)

  • 21. Retroperitoneal laparoscopic lymph node dissection for staging non-seminomatous germ cell tumors before and after chemotherapy.
    Rassweiler JJ; Henkel TO; Stock C; Seemann O; Frede T; Alken P
    Lymphology; 1996 Mar; 29(1):36-44. PubMed ID: 8721978
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A simple model for predicting nodal metastasis in patients with clinical stage I nonseminomatous germ cell testicular tumors undergoing retroperitoneal lymph node dissection only.
    Nicolai N; Miceli R; Artusi R; Piva L; Pizzocaro G; Salvioni R
    J Urol; 2004 Jan; 171(1):172-6. PubMed ID: 14665870
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of retroperitoneal lymphadenectomy in mature teratoma of the testis.
    Heidenreich A; Moul JW; McLeod DG; Mostofi FK; Engelmann UH
    J Urol; 1997 Jan; 157(1):160-3. PubMed ID: 8976241
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Aortic replacement during post chemotherapy retroperitoneal residual tumor resection for nonseminomatous germ cell tumor: a case report].
    Matsuzaki M; Nakano M; Komatsu H; Ohashi K
    Hinyokika Kiyo; 2005 Dec; 51(12):831-4. PubMed ID: 16440734
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Management of stage I testicular nonseminomatous germ cell tumors with an embryonic carcinomatous component. 18 cases].
    Drianno N; Robert M; Legouffe E; Guiter J; Navratil H
    Prog Urol; 1997 Sep; 7(4):622-7. PubMed ID: 9410322
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Retroperitoneal lymph node dissection in patients with high risk testicular cancer.
    Williams SB; McDermott DW; Dock W; Bahnson E; Berry AM; Steele GS; Richie JP
    J Urol; 2009 May; 181(5):2097-101; discussion 2101-2. PubMed ID: 19286227
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Surgery for testicular cancer: indication, results and technical aspects.
    Khouni H; Ghozzi S; Ramzi K; Smaali CH; Majed H; Ben Rais N
    Tunis Med; 2005 Dec; 83 Suppl 12():78-83. PubMed ID: 16430075
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Malignant retroperitoneal and abdominal germ cell tumors: an intergroup study.
    Billmire D; Vinocur C; Rescorla F; Colombani P; Cushing B; Hawkins E; Davis M; London WB; Lauer S; Giller R;
    J Pediatr Surg; 2003 Mar; 38(3):315-8; discussion 315-8. PubMed ID: 12632341
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Does the presence of extranodal extension in pathological stage B1 nonseminomatous germ cell tumor necessitate adjuvant chemotherapy?
    Beck SD; Cheng L; Bihrle R; Donohue JP; Foster RS
    J Urol; 2007 Mar; 177(3):944-6. PubMed ID: 17296383
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [A case of synchronous cervical lymph node metastases from testicular and thyroid cancers showing mixed response to chemotherapy].
    Matsumoto H; Nakane H; Aoki A; Naito K; Imate Y; Ohkami K; Isoyama R
    Hinyokika Kiyo; 2000 Jul; 46(7):505-8. PubMed ID: 10965461
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Resection of pulmonary metastases following chemotherapy for high stage testicular tumors.
    Eskicorapci SY; Ekici S; Atsu MN; Dogan R; Ozen H
    Int J Urol; 2004 Aug; 11(8):634-9. PubMed ID: 15285754
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Does retroperitoneal lymph node dissection have a curative role for patients with sex cord-stromal testicular tumors?
    Mosharafa AA; Foster RS; Bihrle R; Koch MO; Ulbright TM; Einhorn LH; Donohue JP
    Cancer; 2003 Aug; 98(4):753-7. PubMed ID: 12910519
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aortic replacement during post-chemotherapy retroperitoneal lymph node dissection.
    Beck SD; Foster RS; Bihrle R; Koch MO; Wahle GR; Donohue JP
    J Urol; 2001 May; 165(5):1517-20. PubMed ID: 11342909
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk of systemic metastases in clinical stage I nonseminoma germ cell testis tumor managed by retroperitoneal lymph node dissection.
    Hermans BP; Sweeney CJ; Foster RS; Einhorn LE; Donohue JP
    J Urol; 2000 Jun; 163(6):1721-4. PubMed ID: 10799168
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Treatment of germ cell tumors at the threshold of the third millennium].
    Géczi L; Biron P; Droz JP
    Orv Hetil; 2001 Aug; 142(31):1673-9. PubMed ID: 11556261
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Management of testicular seminoma advanced disease. Report on 14 cases and review of the literature.
    Porcaro AB; Antoniolli SZ; Maffei N; Beltrami P; Bassetto MA; Curti P
    Arch Ital Urol Androl; 2002 Jun; 74(2):81-5. PubMed ID: 12161942
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cisplatin-based chemotherapy of primary extragonadal germ cell tumors. A single institution experience.
    Gerl A; Clemm C; Lamerz R; Wilmanns W
    Cancer; 1996 Feb; 77(3):526-32. PubMed ID: 8630961
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Retroperitoneal lymphadenectomy in disseminated non-seminoma germinogenic testicular tumors after chemotherapy in patients with elevated serum tumor markers].
    Matveev VB; Volkova MI; Cherniev VA; Figurin KM; Mitin AV
    Urologiia; 2010; (3):41-7. PubMed ID: 20734877
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Management of advanced seminoma: retrospective study of 96 patients].
    Bompas E; Fléchon A; Biron P; Droz JP
    Bull Cancer; 2002 Oct; 89(10):877-85. PubMed ID: 12441279
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recurrence pattern and proposed surveillance protocol following post-chemotherapy retroperitoneal lymph node dissection.
    Spiess PE; Brown GA; Liu P; Tu SM; Tannir NM; Evans JG; Kamat AM; Kassouf W; Pisters LL
    J Urol; 2007 Jan; 177(1):131-8. PubMed ID: 17162023
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 85.